Erratum to Neutrophil myeloperoxidase: Soldier and statesman (Arch. Immunol. Ther. Exp., (2012), 60, (43-54), 10.1007/s00005-011-0156-8);Neutrophil myeloperoxidase: Soldier and statesman

Archivum Immunologiae et Therapiae Experimentalis

Volumn 60, Issue 1, 2012, Pages 43-54

  Prokopowicz, Zofia ^a   Marcinkiewicz, Janusz ^b   Katz, David R ^a   Chain, Benjamin M ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

Author keywords

Acute and chronic inflammation; Hypochlorous acid; Myeloperoxidase; Neutrophils

Indexed keywords

ALDEHYDE; CHLORAMINE DERIVATIVE; HYDROXYL RADICAL; HYPOCHLOROUS ACID; MYELOPEROXIDASE; OZONE; SINGLET OXYGEN;

ADAPTIVE IMMUNITY; ALZHEIMER DISEASE; ATHEROSCLEROSIS; BACTERICIDAL ACTIVITY; CYSTIC FIBROSIS; ENZYME ACTIVITY; ENZYME INACTIVATION; ENZYME MODIFICATION; ENZYME REGULATION; ENZYME SYNTHESIS; ENZYMOLOGY; HUMAN; INFLAMMATION; KIDNEY DISEASE; MALIGNANT NEOPLASTIC DISEASE; MICROENVIRONMENT; MOLECULAR PATHOLOGY; MULTIPLE SCLEROSIS; NEGATIVE FEEDBACK; NEUTROPHIL; NONHUMAN; PARKINSON DISEASE; PATHOPHYSIOLOGY; PHAGOLYSOSOME; PROTEIN INTERACTION; REVIEW; RHEUMATOID ARTHRITIS; TISSUE DISTRIBUTION; VASCULITIS;

EID: 84858795011     PISSN: 0004069X     EISSN: 16614917     Source Type: Journal    
DOI: 10.1007/s00005-014-0321-y     Document Type: Erratum

References (125)

1. Adachi H, Tsujimoto M (2006) Endothelial scavenger receptors. Prog Lipid Res 45:379-404
2. Alderman CJ, Bunyard PR, Chain BM et al (2002a) Effects of oxidised low density lipoprotein on dendritic cells: a possible immunoregulatory component of the atherogenic micro-environment? Cardiovasc Res 55:806-819
3. Alderman CJ, Shah S, Foreman JC et al (2002b) The role of advanced oxidation protein products in regulation of dendritic cell function. Free Radic Biol Med 32:377-385 (Pubitemid 34178347)
4. Allen RC, Stjernholm RL, Steele RH (1972) Evidence for the generation of an electronic excitation state(s) in human polymorphonuclear leukocytes and its participation in bactericidal activity. Biochem Biophys Res Commun 47:679-684
5. Allison ME, Fearon DT (2000) Enhanced immunogenicity of aldehyde-bearing antigens: a possible link between innate and adaptive immunity. Eur J Immunol 30:2881-2887
6. Andrews PC, Krinsky NI (1981) The reductive cleavage of myeloperoxidase in half, producing enzymically active hemimyeloperoxidase. J Biol Chem 256:4211-4218
7. Aratani Y, Koyama H, Nyui S et al (1999) Severe impairment in early host defense against Candida albicans in mice deficient in myeloperoxidase. Infect Immun 67:1828-1836 (Pubitemid 29144403)
8. Aratani Y, Kura F, Watanabe H et al (2000) Differential host susceptibility to pulmonary infections with bacteria and fungi in mice deficient in myeloperoxidase. J Infect Dis 182:1276-1279
9. Aratani Y, Kura F, Watanabe H et al (2002) Critical role of myeloperoxidase and nicotinamide adenine dinucleotide phosphate-oxidase in high-burden systemic infection of mice with Candida albicans. J Infect Dis 185:1833-1837 (Pubitemid 34615484)
10. Arisawa F, Tatsuzawa H, Kambayashi Y et al (2003) MCLA-dependent chemiluminescence suggests that singlet oxygen plays a pivotal role in myeloperoxidase-catalysed bactericidal action in neutrophil phagosomes. Luminescence 18:229-238 (Pubitemid 40326822)
11. Arnhold J, Flemmig J (2010) Human myeloperoxidase in innate and acquired immunity. Arch Biochem Biophys 500:92-106
12. Babior BM (2004) NADPH oxidase. Curr Opin Immunol 16:42-47
13. Babior BM, Takeuchi C, Ruedi J et al (2003) Investigating antibody-catalyzed ozone generation by human neutrophils. Proc Natl Acad Sci USA 100:3031-3034 (Pubitemid 36358199)
14. Bergt C, Pennathur S, Fu X et al (2004) The myeloperoxidase product hypochlorous acid oxidizes HDL in the human artery wall and impairs ABCA1-dependent cholesterol transport. Proc Natl Acad Sci USA 101:13032-13037 (Pubitemid 39167578)
15. Borregaard N, Cowland JB (1997) Granules of the human neutrophilic polymorphonuclear leukocyte. Blood 89:3503-3521 (Pubitemid 27227073)
16. Brennan ML, Anderson MM, Shih DM et al (2001a) Increased atherosclerosis in myeloperoxidase-deficient mice. J Clin Invest 107:419-430 (Pubitemid 32167988)
17. Brennan M, Gaur A, Pahuja A et al (2001b) Mice lacking myeloperoxidase are more susceptible to experimental autoimmune encephalomyelitis. J Neuroimmunol 112:97-105
18. Carrasco-Marin E, Paz-Miguel JE, Lopez-Mato P et al (1998) Oxidation of defined antigens allows protein unfolding and increases both proteolytic processing and exposes peptide epitopes which are recognized by specific T cells. Immunology 95:314-321 (Pubitemid 28505685)
19. Chapman AL, Hampton MB, Senthilmohan R et al (2002) Chlorination of bacterial and neutrophil proteins during phagocytosis and killing of Staphylococcus aureus. J Biol Chem 277: 9757-9762 (Pubitemid 34968078)
20. Chapman AL, Skaff O, Senthilmohan R et al (2009) Hypobromous acid and bromamine production by neutrophils and modulation by superoxide. Biochem J 417:773-781
21. Chen H, Zhang SM, Hernan MA et al (2003) Nonsteroidal antiinflammatory drugs and the risk of Parkinson disease. Arch Neurol 60:1059-1064 (Pubitemid 36975791)
22. Chiang CL, Ledermann JA, Rad AN et al (2006) Hypochlorous acid enhances immunogenicity and uptake of allogeneic ovarian tumor cells by dendritic cells to cross-prime tumor-specific T cells. Cancer Immunol Immunother 55:1384-1395 (Pubitemid 44187670)
23. Chiang CL, Ledermann JA, Aitkens E et al (2008) Oxidation of ovarian epithelial cancer cells by hypochlorous acid enhances immunogenicity and stimulates T cells that recognize autologous primary tumor. Clin Cancer Res 14:4898-4907
24. Choi DK, Pennathur S, Perier C et al (2005) Ablation of the inflammatory enzyme myeloperoxidase mitigates features of Parkinson's disease in mice. J Neurosci 25:6594-6600 (Pubitemid 40995291)
25. Cramer R, Soranzo MR, Dri P et al (1982) Incidence of myeloperoxidase deficiency in an area of northern Italy: histochemical, biochemical and functional studies. Br J Haematol 51:81-87 (Pubitemid 12101981)
26. Davies DJ, Moran JE, Niall JF et al (1982) Segmental necrotising glomerulonephritis with antineutrophil antibody: possible arbovirus aetiology? Br Med J (Clin Res Ed) 285:606 (Pubitemid 12042688)
27. Davies MJ, Hawkins CL, Pattison DI et al (2008) Mammalian heme peroxidases: from molecular mechanisms to health implications. Antioxid Redox Signal 10:1199-1234 (Pubitemid 351634397)
28. de Boer OJ, van der Meer JJ, Teeling P et al (2010) Differential expression of interleukin-17 family cytokines in intact and complicated human atherosclerotic plaques. J Pathol 220:499-508
29. Deimann W (1984) Endogenous peroxidase activity in mononuclear phagocytes. Prog Histochem Cytochem 15:1-58
30. Eyerich K, Rombold S, Foerster S et al (2007) Altered, but not diminished specific T cell response in chronic mucocutaneous candidiasis patients. Arch Dermatol Res 299:475-481 (Pubitemid 350160061)
31. Falk RJ, Jennette JC (1988) Anti-neutrophil cytoplasmic autoantibodies with specificity for myeloperoxidase in patients with systemic vasculitis and idiopathic necrotizing and crescentic glomerulonephritis. N Engl J Med 318:1651-1657
32. Fu X, Kassim SY, Parks WC et al (2003) Hypochlorous acid generated by myeloperoxidase modifies adjacent tryptophan and glycine residues in the catalytic domain of matrix metalloproteinase-7 (matrilysin): an oxidative mechanism for restraining proteolytic activity during inflammation. J Biol Chem 278:28403-28409 (Pubitemid 36935741)
33. Goedken M, McCormick S, Leidal KG et al (2007) Impact of two novel mutations on the structure and function of human myeloperoxidase. J Biol Chem 282:27994-28003 (Pubitemid 47529491)
34. Goldschmeding R, van der Schoot CE, ten Bokkel HD et al (1989) Wegener's granulomatosis autoantibodies identify a novel diisopropylfluorophosphate- binding protein in the lysosomes of normal human neutrophils. J Clin Invest 84:1577-1587
35. Grone HJ, Grone EF, Malle E (2002) Immunohistochemical detection of hypochlorite-modified proteins in glomeruli of human membranous glomerulonephritis. Lab Invest 82:5-14 (Pubitemid 34072641)
36. Guilpain P, Servettaz A, Batteux F et al (2008) Natural and disease associated anti-myeloperoxidase (MPO) autoantibodies. Autoimmun Rev 7:421-425
37. Haber F, Weiss J (1934) The catalytic decomposition of hydrogen peroxide by iron salts. Proc R Soc Lond A 147:332-351
38. Hansson GK (1999) Inflammation and immune response in atherosclerosis. Curr Atheroscler Rep 1:150-155
39. Hansson M, Olsson I, Nauseef WM (2006) Biosynthesis, processing, and sorting of human myeloperoxidase. Arch Biochem Biophys 445:214-224 (Pubitemid 43082214)
40. Harrison JE, Schultz J (1976) Studies on the chlorinating activity of myeloperoxidase. J Biol Chem 251:1371-1374
41. Hawkins CL, Davies MJ (1998) Hypochlorite-induced damage to proteins: formation of nitrogen-centred radicals from lysine residues and their role in protein fragmentation. Biochem J 332(Pt 3):617-625 (Pubitemid 28306685)
42. Hawkins CL, Davies MJ (2005) Inactivation of protease inhibitors and lysozyme by hypochlorous acid: role of side-chain oxidation and protein unfolding in loss of biological function. Chem Res Toxicol 18:1600-1610 (Pubitemid 41504481)
43. Hawkins CL, Pattison DI, Davies MJ (2003) Hypochlorite-induced oxidation of amino acids, peptides and proteins. Amino Acids 25:259-274 (Pubitemid 38041264)
44. Hawkins CL, Pattison DI, Stanley NR et al (2008) Tryptophan residues are targets in hypothiocyanous acid-mediated protein oxidation. Biochem J 416:441-452
45. He C, Tamimi RM, Hankinson SE et al (2009) A prospective study of genetic polymorphism in MPO, antioxidant status, and breast cancer risk. Breast Cancer Res Treat 113:585-594
46. Henderson JP, Byun J, Williams MV et al (2001) Production of brominating intermediates by myeloperoxidase. A transhalogenation pathway for generating mutagenic nucleobases during inflammation. J Biol Chem 276:7867-7875
47. Hirche TO, Gaut JP, Heinecke JW et al (2005) Myeloperoxidase plays critical roles in killing Klebsiella pneumoniae and inactivating neutrophil elastase: effects on host defense. J Immunol 174: 1557-1565
48. Hoy A, Trégouët D, Leininger-Muller B et al (2001) Serum myeloperoxidase concentration in a healthy population: biological variations, familial resemblance and new genetic polymorphisms. Eur J Hum Genet 9:780-786
49. Jeitner TM, Xu H, Gibson GE (2005) Inhibition of the alpha-ketoglutarate dehydrogenase complex by the myeloperoxidase products, hypochlorous acid and mono-N-chloramine. J Neurochem 92:302-310 (Pubitemid 40194021)
50. Kain R, Exner M, Brandes R et al (2008) Molecular mimicry in pauciimmune focal necrotizing glomerulonephritis. Nat Med 14:1088-1096
51. Kettle AJ, Chan T, Osberg I et al (2004) Myeloperoxidase and protein oxidation in the airways of young children with cystic fibrosis. Am J Respir Crit Care Med 170:1317-1323 (Pubitemid 39657196)
52. King CC, Jefferson MM, Thomas EL (1997) Secretion and inactivation of myeloperoxidase by isolated neutrophils. J Leukoc Biol 61:293-302 (Pubitemid 27149908)
53. Kitahara M, Eyre HJ, Simonian Y et al (1981) Hereditary myeloperoxidase deficiency. Blood 57:888-893 (Pubitemid 11096480)
54. Klebanoff SJ (1967) Iodination of bacteria: a bactericidal mechanism. J Exp Med 126:1063-1078
55. Klebanoff SJ (1999) Myeloperoxidase. Proc Assoc Am Physicians 111:383-389
56. Klebanoff SJ (2005) Myeloperoxidase: friend and foe. J Leukoc Biol 77:598-625
57. Klinke A, Nussbaum C, Kubala L et al (2011) Myeloperoxidase attracts neutrophils by physical forces. Blood 117:1350-1358
58. Kontny E, Maśliński W, Marcinkiewicz J (2003) Anti-inflammatory activities of taurine chloramine: implication for immunoregulation and pathogenesis of rheumatoid arthritis. Adv Exp Med Biol 526:329-340
59. Kutter D, Devaquet P, Vanderstocken G et al (2000) Consequences of total and subtotal myeloperoxidase deficiency: risk or benefit? Acta Haematol 104:10-15
60. Lanza F (1998) Clinical manifestation of myeloperoxidase deficiency. J Mol Med 76:676-681
61. Lehrer RI, Cline MJ (1969) Leukocyte myeloperoxidase deficiency and disseminated candidiasis: the role of myeloperoxidase in resistance to Candida infection. J Clin Invest 48:1478-1488
62. Little MA, Smyth CL, Yadav R et al (2005) Antineutrophil cytoplasm antibodies directed against myeloperoxidase augment leukocytemicrovascular interactions in vivo. Blood 106:2050-2058 (Pubitemid 41291719)
63. Loria V, Dato I, Graziani F et al (2008) Myeloperoxidase: a new biomarker of inflammation in ischemic heart disease and acute coronary syndromes. Mediators Inflamm 2008:135625
64. Malle E, Marsche G, Arnhold J et al (2006) Modification of low-density lipoprotein by myeloperoxidase-derived oxidants and reagent hypochlorous acid. Biochim Biophys Acta 1761:392-415 (Pubitemid 43776460)
65. Marcinkiewicz J (1997) Neutrophil chloramines: missing links between innate and acquired immunity. Immunol Today 18: 577-580
66. Marcinkiewicz J, Chain BM, Olszowska E et al (1991) Enhancement of immunogenic properties of ovalbumin as a result of its chlorination. Int J Biochem 23:1393-1395
67. Marcinkiewicz J, Olszowska E, Olszowski S et al (1992) Enhancement of trinitrophenyl-specific humoral response to TNP proteins as the result of carrier chlorination. Immunology 76: 385-388
68. Marcinkiewicz J, Czajkowska B, Grabowska A et al (1994) Differential effects of chlorination of bacteria on their capacity to generate NO, TNF-alpha and IL-6 in macrophages. Immunology 83:611-616 (Pubitemid 24374095)
69. Marcinkiewicz J, Grabowska A, Bereta J et al (1995) Taurine chloramine, a product of activated neutrophils, inhibits in vitro the generation of nitric oxide and other macrophage inflammatory mediators. J Leukoc Biol 58:667-674 (Pubitemid 26033855)
70. Marquez LA, Dunford HB (1994) Chlorination of taurine by myeloperoxidase. Kinetic evidence for an enzyme-bound intermediate. J Biol Chem 269:7950-7956
71. Marsche G, Weigle B, Sattler W et al (2007) Soluble RAGE blocks scavenger receptor CD36-mediated uptake of hypochlorite-modified low-density lipoprotein. FASEB J 21:3075-3082 (Pubitemid 47565528)
72. Matsuura E, Hughes GR, Khamashta MA (2008) Oxidation of LDL and its clinical implication. Autoimmun Rev 7:558-566
73. Metzler KD, Fuchs TA, Nauseef WM et al (2011) Myeloperoxidase is required for neutrophil extracellular trap formation: implications for innate immunity. Blood 117:953-959
74. Milla C, Yang S, Cornfield DN et al (2004)Myeloperoxidase deficiency enhances inflammation after allogeneic marrow transplantation. Am J Physiol Lung Cell Mol Physiol 287:L706-L714 (Pubitemid 39249383)
75. Muz B, Kontny E, Marcinkiewicz J et al (2008) Heme oxygenase-1 participates in the anti-inflammatory activity of taurine chloramine. Amino Acids 35:397-402
76. Nagra RM, Becher B, Tourtellotte WW et al (1997) Immunohistochemical and genetic evidence of myeloperoxidase involvement in multiple sclerosis. J Neuroimmunol 78:97-107 (Pubitemid 27394430)
77. Naruko T, Ueda M, Haze K et al (2002) Neutrophil infiltration of culprit lesions in acute coronary syndromes. Circulation 106: 2894-2900 (Pubitemid 35424738)
78. Nauseef WM (2007) How human neutrophils kill and degrade microbes: an integrated view. Immunol Rev 219:88-102
79. Nauseef WM, McCormick S, Yi H (1992) Roles of heme insertion and the mannose-6-phosphate receptor in processing of the human myeloid lysosomal enzyme, myeloperoxidase. Blood 80:2622-2633
80. Nauseef WM, McCormick SJ, Clark RA (1995) Calreticulin functions as a molecular chaperone in the biosynthesis of myeloperoxidase. J Biol Chem 270:4741-4747
81. Nauseef WM, McCormick SJ, Goedken M (1998) Coordinated participation of calreticulin and calnexin in the biosynthesis of myeloperoxidase. J Biol Chem 273:7107-7111 (Pubitemid 28160381)
82. Olsson I, Persson AM, Stromberg K (1984) Biosynthesis, transport and processing of myeloperoxidase in the human leukaemic promyelocytic cell line HL-60 and normal marrow cells. Biochem J 223:911-920 (Pubitemid 15209080)
83. Ostrand-Rosenberg S (2008) Immune surveillance: a balance between protumor and antitumor immunity. Curr Opin Genet Dev 18: 11-18
84. Pakakasama S, Chen TT, Frawley W et al (2003) Myeloperoxidase promotor polymorphism and risk of hepatoblastoma. Int J Cancer 106:205-207 (Pubitemid 36835172)
85. Papayannopoulos V, Zychlinsky A (2009) NETs: a new strategy for using old weapons. Trends Immunol 30:513-521
86. Papayannopoulos V, Metzler KD, Hakkim A et al (2010) Neutrophil elastase and myeloperoxidase regulate the formation of neutrophil extracellular traps. J Cell Biol 191:677-691
87. Parry MF, Root RK, Metcalf JA et al (1981) Myeloperoxidase deficiency: prevalence and clinical significance. Ann Intern Med 95:293-301 (Pubitemid 11052697)
88. Pattison DI, Davies MJ (2001) Absolute rate constants for the reaction of hypochlorous acid with protein side chains and peptide bonds. Chem Res Toxicol 14:1453-1464 (Pubitemid 32983270)
89. Pattison DI, Davies MJ (2006) Reactions of myeloperoxidase-derived oxidants with biological substrates: gaining chemical insight into human inflammatory diseases. Curr Med Chem 13:3271-3290 (Pubitemid 44669775)
90. Piedrafita FJ, Molander RB, Vansant G et al (1996) An Alu element in the myeloperoxidase promoter contains a composite SP1-thyroid hormone-retinoic acid response element. J Biol Chem 271:14412-14420
91. Pitt AR, Spickett CM (2008) Mass spectrometric analysis of HOCl-and free-radical-induced damage to lipids and proteins. Biochem Soc Trans 36:1077-1082
92. Podrez EA, bu-Soud HM, Hazen SL (2000) Myeloperoxidase-generated oxidants and atherosclerosis. Free Radic Biol Med 28:1717-1725
93. Porubsky S, Schmid H, Bonrouhi M et al (2004) Influence of native and hypochlorite-modified low-density lipoprotein on gene expression in human proximal tubular epithelium. Am J Pathol 164:2175-2187 (Pubitemid 38669364)
94. Prokopowicz ZM, Arce F, Biedron R et al (2010) Hypochlorous acid: a natural adjuvant that facilitates antigen processing, cross-priming, and the induction of adaptive immunity. J Immunol 184:824-835
95. Prutz WA (1996) Hypochlorous acid interactions with thiols, nucleotides, DNA, and other biological substrates. Arch Biochem Biophys 332:110-120
96. Rainis T, Maor I, Lanir A et al (2007) Enhanced oxidative stress and leucocyte activation in neoplastic tissues of the colon. Dig Dis Sci 52:526-530 (Pubitemid 46202833)
97. Ramos CL, Pou S, Britigan BE et al (1992) Spin trapping evidence for myeloperoxidase-dependent hydroxyl radical formation by human neutrophils and monocytes. J Biol Chem 267:8307-8312
98. Ramos DR, Garcia MV, Canle LM et al (2008) Myeloperoxidase-catalyzed chlorination: the quest for the active species. J Inorg Biochem 102:1300-1311
99. Reynolds WF, Chang E, Douer D et al (1997) An allelic association implicates myeloperoxidase in the etiology of acute promyelocytic leukemia. Blood 90:2730-2737 (Pubitemid 27413483)
100. Reynolds WF, Rhees J, Maciejewski D et al (1999) Myeloperoxidase polymorphism is associated with gender specific risk for Alzheimer's disease. Exp Neurol 155:31-41 (Pubitemid 29072602)
101. Reynolds WF, Sermet-Gaudelus I, Gausson V et al (2006) Myeloperoxidase promoter polymorphism -463G is associated with more severe clinical expression of cystic fibrosis pulmonary disease. Mediators Inflamm 2006:36735
102. Russell JC, Graham SE, Amy RM et al (1998) Cardioprotective effect of probucol in the atherosclerosis-prone JCR:LA-cp rat. Eur J Pharmacol 350:203-210 (Pubitemid 28294047)
103. Rutgers A, Heeringa P, Giesen JE et al (2003a) Neutrophil myeloperoxidase activity and the influence of two single-nucleotide promoter polymorphisms. Br J Haematol 123: 536-538 (Pubitemid 37363501)
104. Rutgers A, Heeringa P, Tervaert JW (2003b) The role of myeloperoxidase in the pathogenesis of systemic vasculitis. Clin Exp Rheumatol 21(6 Suppl 32):S55-S63 (Pubitemid 38016480)
105. Schabath MB, Spitz MR, Hong WK et al (2002) A myeloperoxidase polymorphism associated with reduced risk of lung cancer. Lung Cancer 37:35-40 (Pubitemid 34621456)
106. Schiller J, Fuchs B, Arnhold J et al (2003) Contribution of reactive oxygen species to cartilage degradation in rheumatic diseases: molecular pathways, diagnosis and potential therapeutic strategies. Curr Med Chem 10:2123-2145 (Pubitemid 37139067)
107. Segal AW (2005) How neutrophils kill microbes. Annu Rev Immunol 23:197-223
108. Segal AW (2006) How superoxide production by neutrophil leukocytes kills microbes. Novartis Found Symp 279:92-98
109. Segal AW, Geisow M, Garcia R et al (1981) The respiratory burst of phagocytic cells is associated with a rise in vacuolar pH. Nature 290:406-409 (Pubitemid 11158485)
110. Senthilmohan R, Kettle AJ (2006) Bromination and chlorination reactions of myeloperoxidase at physiological concentrations of bromide and chloride. Arch Biochem Biophys 445:235-244 (Pubitemid 43082216)
111. Shao B, Belaaouaj A, Verlinde CL et al (2005) Methionine sulfoxide and proteolytic cleavage contribute to the inactivation of cathepsin G by hypochlorous acid: an oxidative mechanism for regulation of serine proteinases by myeloperoxidase. J Biol Chem 280:29311-29321 (Pubitemid 41161386)
112. Spalteholz H, Panasenko OM, Arnhold J (2006) Formation of reactive halide species by myeloperoxidase and eosinophil peroxidase. Arch Biochem Biophys 445:225-234 (Pubitemid 43082215)
113. Staudinger BJ, Oberdoerster MA, Lewis PJ et al (2002) mRNA expression profiles for Escherichia coli ingested by normal and phagocyte oxidase-deficient human neutrophils. J Clin Invest 110:1151-1163 (Pubitemid 35215896)
114. Sugiyama S, Okada Y, Sukhova GK et al (2001) Macrophage myeloperoxidase regulation by granulocyte macrophage colony-stimulating factor in human atherosclerosis and implications in acute coronary syndromes. Am J Pathol 158:879-891 (Pubitemid 32221781)
115. Thomas MJ (1992) Urate causes the human polymorphonuclear leukocyte to secrete superoxide. Free Radic Biol Med 12:89-91
116. van Dalen CJ, Whitehouse MW, Winterbourn CC et al (1997) Thiocyanate and chloride as competing substrates for myeloperoxidase. Biochem J 327(Pt 2):487-492 (Pubitemid 27477827)
117. van der Veen BS, de Winther MPJ, Heeringa P (2009) Myeloperoxidase: Molecular mechanisms of action and their relevance to human health and disease. Antioxid Redox Signal 11:2899-2937
118. van Leeuwen M, Gijbels MJ, Duijvestijn A et al (2008) Accumulation of myeloperoxidase-positive neutrophils in atherosclerotic lesions in LDLR-/- mice. Arterioscler Thromb Vasc Biol 28:84-89
119. von Vietinghoff S, Ley K (2008) Homeostatic regulation of blood neutrophil counts. J Immunol 181:5183-5188
120. Wang Y, Rosen H, Madtes DK et al (2007) Myeloperoxidase inactivates TIMP-1 by oxidizing its N-terminal cysteine residue: an oxidative mechanism for regulating proteolysis during inflammation. J Biol Chem 282:31826-31834 (Pubitemid 350106428)
121. Wentworth P Jr, McDunn JE, Wentworth AD et al (2002) Evidence for antibody-catalyzed ozone formation in bacterial killing and inflammation. Science 298:2195-2199 (Pubitemid 35471245)
122. Winterbourn CC, van den Berg JJ, Roitman E et al (1992) Chlorohydrin formation from unsaturated fatty acids reacted with hypochlorous acid. Arch Biochem Biophys 296:547-555
123. Winterbourn CC, Hampton MB, Livesey JH et al (2006) Modeling the reactions of superoxide and myeloperoxidase in the neutrophil phagosome: implications for microbial killing. J Biol Chem 281:39860-39869 (Pubitemid 46041789)
124. Woods AA, Davies MJ (2003) Fragmentation of extracellular matrix by hypochlorous acid. Biochem J 376:219-227 (Pubitemid 37487217)
125. Xiao H, Heeringa P, Hu P et al (2002) Antineutrophil cytoplasmic autoantibodies specific for myeloperoxidase cause glomerulonephritis and vasculitis in mice. J Clin Invest 110:955-963